comparemela.com

Latest Breaking News On - Soumya swaminathan yadav - Page 1 : comparemela.com

Smoking gun: Pfizer logs 1,223 deaths, 42,086 adverse reactions after just three months of vaccine rollout

In a stunning "confession," Pfizer admitted that it has logged a staggering 42,086 adverse reactions – representing a total of 158,893 adverse events – in the first three months of its [.]

El nuevo debate del SARS-CoV-2 frente a la posibilidad de una tercera dosis de vacunas

El nuevo debate del SARS-CoV-2 frente a la posibilidad de una tercera dosis de vacunas
laestrella.com.pa - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laestrella.com.pa Daily Mail and Mail on Sunday newspapers.

La OMS advierte sobre la mezcla de las vacunas COVID-19

La OMS advierte sobre la mezcla de las vacunas COVID-19
urgente24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urgente24.com Daily Mail and Mail on Sunday newspapers.

Behind Every Successful Covid Vaccine Is A Woman

Ayn Rand once famously wrote about women saying, “The question isn’t who is going to let me; it’s who is going to stop me.” Rand may well have written these words for this pandemic. That too in a very unusual but critical vertical: C-19 vaccine research. A number of studies in the mid-2000s revealed that almost 82% of clinical trial principal investigators in the US were men; while the coordinators, who do the really hard day-to-day slog to generate much of the knowledge and insights, were women! The situation is very different in the present scenario as there is at least one woman in a leading role for all the frontrunner Covid vaccines, the vaccine race seems to be largely driven by a powerhouse of women in their 50-60s. The woman most prominent and celebrated in her country: Major General Chen Wei, from the Chinese Academy of Military Medical Sciences, was awarded the People’s Hero title for her leadership roles in phase 3 trial in the development of Sinopharma and CanS

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.